ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VRS Versarien Plc

0.106
-0.0015 (-1.40%)
Last Updated: 11:11:08
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Versarien Plc LSE:VRS London Ordinary Share GB00B8YZTJ80 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0015 -1.40% 0.106 0.103 0.105 0.106 0.106 0.11 1,309,491 11:11:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 11.64M -8.07M -0.0244 -0.05 363.86k
Versarien Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker VRS. The last closing price for Versarien was 0.11p. Over the last year, Versarien shares have traded in a share price range of 0.08p to 6.66p.

Versarien currently has 330,779,690 shares in issue. The market capitalisation of Versarien is £363,858 . Versarien has a price to earnings ratio (PE ratio) of -0.05.

Versarien Share Discussion Threads

Showing 15426 to 15446 of 195575 messages
Chat Pages: Latest  623  622  621  620  619  618  617  616  615  614  613  612  Older
DateSubjectAuthorDiscuss
15/12/2017
11:44
"The Partner has provided its first Nanene purchase order to Versarien"

I think the wording of that is key. IMV that word 'first' means that they have bought some nanene to use in internal testing and trials; and if some or all of those tests and trials work they will then place larger and regular orders, and possibly roll out tests/trials to more product lines.

That's just my take on it, but it certainly fits the wording...

club sandwich
15/12/2017
11:42
Don't know when people are going to relax, get away from the share price and remember what is going on in the background

We have three large/huge organisations buying Nanene and the CPI.

IAI... announced 'We are delighted to be working with IAI, a global leader in aerospace technologies, to incorporate our graphene into a variety of composite structures'

About Israel Aerospace Industries

IAI is a world leader in both the defence and commercial markets, delivering state-of-the-art technologies and systems in all domains: air, space, land, sea, cyber, homeland security and ISR. Drawing on over 60 years of experience developing and supplying innovative, cutting-edge systems for customers around the world, IAI tailors optimized solutions that respond to the unique security challenges facing each customer.

IAI employs its advanced and proven engineering, manufacturing and testing capabilities to develop, produce and support complete systems - from components, sensors and subsystems all the way to large-scale, fully-integrated systems of systems. Â

Dow / Dupont (allegedly but pretty damn sure it is)....

'Neill Ricketts, CEO of Versarien, commented: "This agreement is another significant  collaboration we have agreed to date. We look forward to working closely with our Partner to test and develop materials containing both our high quality Nanene and other 2D materials we are developing.

"This agreement with one of the world's largest chemical and specialist material groups further demonstrates that Versarien is rapidly establishing itself as the go-to supplier of high quality graphene and other potentially industry disruptive 2D materials.  The fact that we are able to offer not just high quality product, but have significant research capabilities in conjunction with the Universities of Manchester and Cambridge, gives us a strong competitive position and is putting us at the forefront of graphene's commercialisation.'

Unilever... (allegedly but pretty damn sure it is also)

'The Partner has provided its first Nanene purchase order to Versarien. Â The Nanene will be incorporated into polymer structures, primarily for packaging applications, for testing and evaluation, with a view to improving material strength, moisture control and recyclability.'


Obviously they were all under NDA's prior to their current decisions to go ahead, any problems and VRS can Leverage £1 billion of support to iron them out, these large buyers of the product have already tested it in one form or another and now they are going for it. Nanene does what they say it does.

Now they are progressing more than 50% of the way there NR is not going to let them go easily is he?

If just one of the current ones place an order for large production runs it's phenomenal and there are still more in the process of signing up, what's not to like!

luckyorange
15/12/2017
11:30
Well if it hangs around in the mid 60's pre any more big news to come then the market would open it higher perhaps 10% or more. Then after the initial buying they spike it up again so 80p in no time depending on how tight stock is.

That is generally when the herd buy, when the price is spiking up.

superg1
15/12/2017
11:16
Yes Fest, let’s hope some more volume of buys this arvo so we end decently up, not flat. Would be good to stop the drift.
richardc77
15/12/2017
11:11
Identical chart to yesterday.
festario
15/12/2017
11:06
I literally have no clue what they are saying, so it’s all good 😉
richardc77
15/12/2017
11:03
Richard

It gets to them so smile to go to those length it must do, strange bunch. But still not so strange as the folk in the back room of the Set.

I was banging on their door all evening on one visit to the Set and eventually they let me out. :-)

superg1
15/12/2017
11:00
ah diddums
the stigologist
15/12/2017
10:53
Oh man, the filtered tw@ts are back 😂
richardc77
15/12/2017
10:53
stig..just be a good boy and behave yourself. Xmas is not far away and then you can throw all the tantrums you like......
phoenixs
15/12/2017
10:38
FT article on IOF and their army of gullible investors (read superg1 and his sheep)

Here is the FT piece:

FT - 22/12/13:

Why iodine may be needed to bathe shareholders’ wounds

Small Talk’s 2013 award for volatility goes to iodine extractor Iofina

V is for victory and vociferousness. But also volatility.

This year’s Small Talk award for vociferousness goes to the Aim team at the London Stock Exchange, for lobbying the government until it agreed to let private investors put Aim shares into individual savings accounts.

Small Talk’s less sought-after 2013 award for volatility goes to Iofina, the Aim-quoted darling of bulletin boards and private investors who own about half of the shares. Iofina, which extracts iodine from waste water from the shale oil industry for use in anything from disinfectants to paints and computer screens, is typical of small, speculative enterprises on Aim that catch hobbyist investors’ eyes. Its share price chart illustrates just what a mixed blessing it can be for a share register to include hordes of private investors.

Iofina’s shares – which Chris Fay, the group’s ebullient chairman, says are the most heavily traded on Aim – more than doubled between January and May to about 245p. Then in June, they fell 40 per cent in a day for no reason that the company could think of. They veered between 150p and 200p until an update last week knocked another one-third of the price. At 86p, the shares are lower than they were a year ago.

That is despite the company’s proving that its patented technology to extract iodine works and at a fraction of the cost of other producers.

This year Iofina rolled out three plants in the US and reported first-half revenues 50 per cent higher with pre-tax losses narrowed from $1m to $0.1m.

The fourth and fifth plants are now on track to begin pumping the purple stuff in early 2014 and construction of the sixth has started. Consensus forecasts suggest pre-tax profits will be more than £25m by December 2014 and £40m the year after.

That said, last week’s update was disappointing, emphasising that Iofina is still at an early stage. The company warned that delays in booking sales meant full-year revenues and earnings would do no more than match last year’s. It is clear that Iofina’s long-term success rests on tying down reliable flows of dirty water from other energy companies on profitable terms. It also has to find markets for its raw and refined product.

Iofina may yet become one of America’s biggest producers of purple crystals, but it will still be dwarfed by rivals in Chile and Japan which churn out four-fifths of the world’s supplies.

The challenge for all small companies is to sell the positive news without over-promising.

For Iofina’s board, the challenge is greater because so many shares are held by private investors. Institutional investors understand the risks in ventures such as Iofina. They have deep pockets and can sit out bouts of turbulence. Private investors may not have that luxury.

The LSE argued that giving private investors greater access to the junior market would lift trading volumes, ease liquidity and reinvigorate share prices of Aim companies.

The quid pro quo is that Aim boards must work harder on managing expectations. Either that – or keep the iodine on hand to cleanse their, and their shareholders’, wounds.

failed iof ramper superg1
15/12/2017
10:37
his deceitful ramping cost people a lot of money in IOF

worraps 17 Dec '13 - 12:37 - 13064 of 41441 10 1

At the end of the day, superg, all that research.....where did it get you? Or us? Every single prediction, every single nudge, wink, nod, and THE PING, has spectacularly failed. I am not a de-ramper, or a troll. I have put my life savings in here. It was my decision only. My finger of blame is pointing at myself. But, really.......research? Gut instinct would have saved me a fortune, the market was talking to me, but I didn't listen!!

worraps 17 Dec '13 - 13:01 - 13073 of 41441 3 0

I'm not blaming superg. I'm just asking....where did all that research get anyone? This situation is making a mockery of 'research'. It was as a result of 'research' that £5 - £6 was being forecast for end of this year, and six fully operational plants. We have a very different picture of things in reality. We have been bombarded day in and day out about the value of research, and the superior position it puts superg in as a result of it. Somehow, today, it all seems a bit bizarre. Even a day or two ago, we were being told we were stupid if we sold, and we should all be buying!! It was the 'research' that told us that.

If superg, and his pals (most of whom I really respected), really have been deliberately mis-led by the company, then I suggest legal action is sought immediately!!

ramu kumar 17 Dec '13 - 15:33 - 13135 of 41441 4 0

Not a squeak from SG and his cronies......says it all, doesn't it?

failed iof ramper superg1
15/12/2017
10:32
It was right about Allianz, It was right about Lombard and City finance. Wins and Peel dealt with one lot and Peel dealt with all of Lombard.

Cantor normally don't do more than about 100k shares. That means they had a supply just like Wins and Peel in the past. I wasn't the only one to spot it.

Imo it pays to understand how the MMs react and who the supply is as then you have a better insight to likely moves and when.

The suggestion was to make the most of the Lombard supply and buy on those lows as once such a big supply had gone it would bounce then with news it would go higher.

Plenty bought at 14p and one I know picked up about 750k there based on the supply situation the company advancing. VRS said things were looking very good and expected big name news.

So I imagine he is quite happy tbh but it was an easy call if people had done their research

superg1
15/12/2017
10:19
Here we go again, someone speaking about "Cantor excess supply".
Cantor this and cantor that could be a No.1 song for Christmas.
I am really laughing.

fuji99
15/12/2017
10:12
What hyping and speculating caused it to spike to 90p you muppet?

90p happened on the day of the Fortune 100 Chemicals company announcement

Do you think the RNS was hype and speculation ?

Fukkin cretin

the stigologist
15/12/2017
10:10
I've just been going on MM behaviour. Cantor for a free days clearly had a supply. They kept trying to kid the market by going on the bid but with no stock picked up they would them go back on the offer. They were doing it all day long for a few days.

Yesterday morning they seemed to stop and a small tick up, then same today volume not high yet share price going up.

superg1
15/12/2017
10:08
patient: will you PLEASE STOP hyping and speculating, it is undignified, and is extremely unhelpful in that people buy expecting to much all at once and we get a bubble as we did earlier with traders and others spiking it up to 90.

Look at the amount this has already risen in a very short period. Let it rise slowly and surely (inbetween positive RNs's).

And last but not least have patience!

Thank you.
Best wishes - Mike

spike_1
15/12/2017
10:07
Just a final point re Directa.

As they sold 3.1 tonnes for about £600k which is 20 pence per gram it gives some idea re what it is v graphene sold at over £100 per gram.

So the entire 30 tonnes would come out at £6 mill and they have something like 4 mill losses on the lower levels.

No TDS or MDS that I can find to identify exactly what they are selling but at 20p average it's obviously graphite.

superg1
15/12/2017
10:03
After yesterday’s similar action I will wait for close to see if we are up 5-6p or like yesterday it fizzles out. Would be great to end the year with an RNS and a share price that starts with 7x or 8x (of course I’ll settle for higher too;))
richardc77
15/12/2017
10:03
an RNS can not 'come anytime'

please do tell me how many RNSes get released between 18:30 and 07:00 ?

how many RNSes get released on a Sunday ?

the stigologist
15/12/2017
09:56
JH your sonic screwdriver needs new batteries.
festario
Chat Pages: Latest  623  622  621  620  619  618  617  616  615  614  613  612  Older

Your Recent History

Delayed Upgrade Clock